AKRO stock results show that Akero Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. More
Articles
ZNTL Stock Earnings: Zentalis Pharma Misses EPS for Q2 2024
ZNTL stock results show that Zentalis Pharma missed analyst estimates for earnings per share the second quarter of 2024. More
MNPR Stock Earnings: Monopar Therapeutics Misses EPS for Q2 2024
MNPR stock results show that Monopar Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. More
ENV Stock Earnings: Envestnet Misses EPS, Beats Revenue for Q2 2024
ENV stock results show that Envestnet missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. More
NGNE Stock Earnings: Neurogene Misses EPS for Q2 2024
NGNE stock results show that Neurogene missed analyst estimates for earnings per share the second quarter of 2024. More
ACST Stock Earnings: Acasti Pharma Beats EPS for Q1 2025
ACST stock results show that Acasti Pharma beat analyst estimates for earnings per share the first quarter of 2025. More
GETY Stock Earnings: Getty Images Holdings Misses EPS, Beats Revenue for Q2 2024
GETY stock results show that Getty Images Holdings missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. More
